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What does this review add?  
x To our knowledge, this is the first systematic review regarding the effects of 
Spinal Cord Stimulation on brain activity. 
x This review draws together the existing knowledge from functional imaging 
literature on the effects of SCS on the brain. 
x This review highlights gaps in current knowledge and stresses the importance 
of continued research in this field, suggesting directions for future research 
which could significantly enhance understanding of the supraspinal 
mechanisms of Spinal Cord Stimulation. 
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Abstract:  
Background and objective: Spinal Cord Stimulation is believed to exert supraspinal effects; 
however these mechanisms are still far from fully elucidated. This systematic review aims to 
assess existing neurophysiological and functional neuroimaging literature to reveal current 
knowledge regarding the effects of SCS for chronic neuropathic pain on brain activity, to 
identify gaps in knowledge, and to suggest directions for future research. 
Databases and data treatment: Electronic databases and hand-search of reference lists were 
employed to identify publications investigating brain activity associated with SCS in patients 
with chronic neuropathic pain, using neurophysiological and functional neuroimaging 
techniques (fMRI, PET, MEG, EEG). Studies investigating patients with SCS for chronic 
neuropathic pain and studying brain activity related to SCS were included. Demographic data 
(age, gender), study factors (imaging modality, patient diagnoses, pain area, duration of SCS 
at recording, stimulus used) and brain areas activated were extracted from the included 
studies. 
Results: Twenty-four studies were included. Thirteen studies used neuroelectrical imaging 
techniques, eight studies used haemodynamic imaging techniques, two studies employed both 
neuroelectrical and haemodynamic techniques separately, and one study investigated cerebral 
neurobiology. 
Conclusions: The limited available evidence regarding supraspinal mechanisms of SCS does 
not allow us to develop any conclusive theories. However, the studies included appear to 
show an inhibitory effect of SCS on somatosensory evoked potentials, as well as identifying 
the thalamus and anterior cingulate cortex as potential mediators of the pain experience. The 
lack of substantial evidence in this area highlights the need for large scale controlled studies 
of this kind. 
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Introduction 
Spinal cord stimulation (SCS), since its initial report in 1967 (Shealy et al., 1967), has 
provided substantial pain relief for many patients suffering from chronic neuropathic pain. 
The treatment initially emerged following the development of the Gate Control Theory 
(Melzack and Wall, 1965) which suggested that the transmission of pain signals could be 
inhibited at the dorsal horn of the spinal cord by the stimulation of large-diameter nerve 
fibres. The effectiveness of SCS for the management of complex regional pain syndrome 
(Kemler et al., 2000) and failed back surgery syndrome (Kumar et al., 2007) has been 
confirmed by randomised controlled trials. The analgesic mechanisms of SCS at a spinal 
level have been well documented (Linderoth and Foreman, 1999; Linderoth, 2009; Meyerson 
and Linderoth, 2006) and the existence of descending inhibitory processes stemming from a 
cortical level during chronic pain is widely accepted (Tracey and Mantyh, 2007; Tracey, 
2008). However, the effect that SCS has on these supraspinal processes is still far from fully 
elucidated. Neurophysiological and functional neuroimaging techniques provide a unique 
means of non-invasively studying these processes and increasing our understanding of the 
underlying mechanisms of SCS. 
 
To our knowledge, the functional imaging literature regarding the effects of SCS on human 
brain mechanisms has not been systematically reviewed. This systematic review assesses the 
published work investigating the effects of SCS for chronic neuropathic pain on cortical and 
subcortical processing, as elucidated by neurophysiological and functional imaging 
techniques. The aim of this systematic review is to reveal the extent of current knowledge, 
identify knowledge gaps and suggest directions for future research. 
 
Method 
Search strategy 
Publications which addressed the effects of SCS on human brain activity in chronic pain 
patients were reviewed. We searched MEDLINE, PubMed, and EMBASE electronic 
databases from 1967 (when SCS was first described) to 31 December 2014.  A combination 
of MeSH and free-text terms were used, including: spinal cord stimulation; SCS; 
neurostimulation; functional magnetic resonance imaging; fMRI; positron emission 
tomography; PET; electroencephalography; EEG; magnetoencephalography; MEG; and 
somatosensory evoked potentials. The search was restricted to English language publications 
involving human participants. Hand-search of the reference lists of all included articles were 
also explored for further relevant papers. 
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Selection of studies 
Papers were included in the review if they met the following inclusion criteria: (i) patients 
were treated using SCS for chronic neuropathic pain; (ii) a technique was employed to 
investigate brain activity related to SCS. Publications were excluded from the review if they 
met any of the following exclusion criteria: (i) articles were reviews, not presenting original 
research or abstracts of conference proceedings for which no full peer-reviewed articles have 
been published; (ii) they did not include SCS patients; (iii) patients were being treated with 
SCS for conditions other than chronic neuropathic pain (e.g. angina pectoris) or type of pain 
was not specified; (iv) techniques employed were not measuring brain activity. An initial 
screen of titles and abstracts retrieved by the search was conducted by two independent 
reviewers (LDB and RVD). Full texts of all potentially eligible studies were retrieved. Two 
review authors (LDB and RVD) independently examined these for compliance with the 
inclusion criteria and selected the appropriate studies. Disagreements as to eligibility were 
resolved by discussion or by a third review author (JHR).  
 
Data extraction 
Data from eligible studies was extracted using a data extraction form designed for this 
review. Data extracted included study characteristics and outcome data. Data collected with 
the data extraction form included: author, date of publication, patient factors (age, gender), 
study factors (imaging modality, patient diagnosis, pain area, duration of SCS at recording, 
stimulus used) and brain areas activated. Where studies had multiple publications (e.g. 
conference abstract and full paper), we used the main report as the reference and derived 
additional details from secondary papers. Data extracted is reported descriptively. 
 
Results 
From 1277 articles which were identified as potentially eligible for inclusion in this review, 
33 met our inclusion criteria (Fig. 1). After scrutiny of the full-text publications, a further 
nine publications were excluded: four were abstracts of conference proceedings, two of 
which had no full-text publication available for further clarification of study factors 
(Buonocore and Demartini, 2014; Oluigbo et al., 2012), and two of which presented data 
which was also available in full-text articles included within this review (Moens et al., 2012b, 
2013b); two reviewed previous research and were not presenting original data (García-Larrea 
et al., 2000; Zonenshayn et al., 2000); one did not specify the type of pain being investigated 
(Balzer et al., 2011); one was not measuring brain activity (North et al., 2012); and one was 
not investigating the effect of SCS on brain activity (Paradiso et al., 1995). 
 
Twenty-four studies were included in the systematic review: thirteen used neuroelectrical 
imaging techniques (de Andrade et al., 2010; Augustinsson et al., 1979; Blair et al., 1975; 
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Buonocore et al., 2012; Doerr et al., 1978; Gildenberg and Murthy, 1980; Pahapill and 
Zhang, 2014; Pluijms et al., 2015; Poláček et al., 2007; Schlaier et al., 2007; Schulman et al., 
2005; Theuvenet et al., 1999; Wolter et al., 2013); eight used haemodynamic imaging 
techniques (Hosobuchi, 1985; Kiriakopoulos et al., 1997; Kishima et al., 2010; Kunitake et 
al., 2005; Meglio et al., 1991; Moens et al., 2012a; Nagamachi et al., 2006; Stančák et al., 
2008); two used both neuroelectrical and haemodynamic techniques, which are discussed 
respectively in the following two sections (Mazzone et al., 1995; Sufianov et al., 2014); and 
one investigated cerebral neurobiology, which is discussed within the section on 
haemodynamic studies (Moens et al., 2013a). The results of the study selection process are 
displayed in Figure 1. 
 
 
Figure 1 Results of study selection process 
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Neuroelectrical studies 
Fifteen papers included in this review involved the implementation of neuroelectrical 
imaging techniques (electroencephalography (EEG), magnetoencephalography (MEG), 
transcranial magnetic stimulation (TMS), intracranial recordings) to study the effect of SCS 
on cortical processing (Table 1). These studies largely examined this effect by investigating 
the influence of SCS on somatosensory evoked potentials/magnetic fields (SEPs/SEFs) to 
either innocuous or painful peripheral nerve stimulation. In particular, seven of the 
neuroelectrical studies in this review used EEG to investigate the effects of SCS on SEPs 
following innocuous tibial nerve stimulation (de Andrade et al., 2010; Blair et al., 1975; 
Buonocore et al., 2012; Mazzone et al., 1995; Poláček et al., 2007; Theuvenet et al., 1999; 
Wolter et al., 2013). Of these studies, all except one found SCS to have an inhibitory effect 
on the amplitude of these responses, however the latency of this attenuation differed across 
the studies. The study which did not find a clear inhibitory effect only observed an SCS 
related change in the later P300 component, with this component appearing in one patient, 
increasing in amplitude in one patient and remaining unchanged in a further two (Mazzone et 
al., 1995). Although not unanimous, the results of these studies along with others using MEG 
or different types of peripheral nerve stimulation strongly suggest that SCS may contribute to 
an inhibitory effect on somatosensory processing in the cortex. In addition to this, 
intracerebral recordings also found evidence suggesting that SCS modifies evoked responses 
to innocuous and painful peripheral nerve stimulation at a thalamic level (Augustinsson et al., 
1979; Gildenberg and Murthy, 1980).  
 
It was also observed that SCS was able to reverse cortical disorganisation of digit 
representations in the primary somatosensory cortex (S1) (Pahapill and Zhang, 2014) and that 
patients treated successfully with SCS show a comparable cortical power spectra to that of 
healthy controls (Schulman et al., 2005). Furthermore, the only TMS study conducted within 
this research area found that SCS normalised intracortical facilitation, suggesting that SCS 
may also have an effect on cortical excitability and neurobiological processes at a supraspinal 
level (Schlaier et al., 2007). These studies demonstrate the possible role of SCS in 
transforming pathological cortical processing in patients with chronic pain into a more 
healthy state of cortical functioning. 
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Table 1 Summary of findings from neuroelectrical studies investigating the effect of SCS on cortical processing 
 Imaging modality Na; 
Gender 
Ageb Patient diagnoses Pain area Duration of SCS 
at recording 
Stimulus Findings 
de Andrade et 
al. 2010 
EEG 20; 12 
Male 
49.1 (36-66) FBSS Legs & low back 1-13 years (Mean 
= 5.7 years) 
Tibial nerve 
stimulation (motor 
twitch) 
 
SCS ↓ P40-SEP amplitude 
Poláček et al. 
2007 
EEG 9; 4 Male Range 37-58 FBSS Left leg/lower back 12-43 months Tibial nerve (motor 
threshold) & sural 
nerve (10% > pain 
threshold) stimulation 
SCS ↓ SEP amplitude in cS1, 
bS2, & MCC to tibial nerve 
stimulation.  
SCS ↓ PREP amplitude in cS1 
& bS2 but ↑ PREP amplitude in 
MCC to sural nerve stimulation 
 
Sufianov et al., 
2014 
EEG 30; 18 
Male 
48.7 ± 2.3 FBSS NR Pre-implant & 3 
months post-
implantation 
 
Resting state 
recordings pre- and 
post-implantation of 
SCS 
 
Pre-SCS: ↓ α-band frequency 
& ↑ δ-, θ-, & β-band 
amplitudes compared to healthy 
controls  
Post-SCS: normalisation of α-
band frequency & 
normalisation/significant 
amplitude ↓ across the total 
frequency range 
  
Buonocore et 
al. 2012 
EEG 10; 4 Male 55.3 (42-72) FBSS, lumbar 
radiculopathy, 
polyneuropathy 
Legs NR Tibial nerve 
stimulation (motor 
twitch) 
SCS ↓ amplitude of P39N50 
component. Amplitudes 
returned to baseline with SCS 
off again 
 
Wolter et al. 
2013 
EEG 10; 4 Male 54 ± 10.2 
(40.7-77.2) 
FBSS, neuropathic 
knee pain 
Legs 3.9 ± 3.8 years 
(0.2-12.3) 
Tibial nerve 
stimulation (motor 
twitch) 
SCS & TENS ↓ amplitude of 
P40N50 (S1) SEP component 
but SCS showed greater 
attenuation.  
SCS ↓ amplitude of N50P60 
SEP component 
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Pluijms et al. 
2015 
 
EEG 15; 8 Male 59.9 (50-72) Diabetic 
polyneuropathy 
Legs Pre-implant & 2 
weeks post-
implant (trial 
SCS) 
 
CHEPs at dorsal 
forearm, volar forearm, 
& lower leg 
Pre- vs Post-SCS: Dorsal P2 
latency ↓ post-SCS 
SCS Responders vs Non-
responders: Volar forearm N2 
& dorsal forearm N2 & P2 
latencies ↑ in SCS responders 
 
Blair et al. 1975 EEG 6; 3 Male Range 28-52 Lumbar 
radiculopathy, 
cauda equina 
syndrome, chronic 
pancreatitis 
NR ≤ 1 month Tibial nerve 
stimulation (motor 
twitch) 
SCS ↓ amplitude of late SEP 
components (200-300ms). 
Greater than clinically relevant 
SCS intensities ↓ amplitude of 
all SEP components 
 
Mazzone et al. 
1995 
EEG 4; 2 Male Range 22-78 Mixed pathologies NR NR Tibial nerve 
stimulation (20% 
above sensory 
threshold) 
No change to early SEP 
components with SCS. P300 
component appeared in 1 
patient, ↑ in amplitude in 1 
patient and remained unchanged 
in 2 patients with SCS 
 
Doerr et al. 
1978 
EEG 25; 25 
Male 
Range 35-60 Post amputation 
pain, brachial 
plexus lesion 
NR NR Median nerve 
stimulation (motor 
threshold) 
 
No change to SEPs with SCS 
Theuvenet et al. 
1999 
EEG/MEG 3; 2 Male Range 47-69 Mixed neuropathies Foot/hand 3 days pre-
implant; trial 
SCS; 6 months-3 
years post-
implantation 
 
Median & posterior 
tibial nerve stimulation 
(motor twitch) 
SCS ↓ amplitude of 80-150ms 
SEP/SEF component 
Pahapill & 
Zhang 2014 
MEG 1; Female 41 CRPS type 1 Right arm NR Tactile finger 
stimulation 
Disorganisation/inversion of 
D1/D5 cortical representation in 
S1 was normalised with SCS 
 
Schulman et al. 
2005 
MEG 5; Gender 
NR 
41.5 ± 6.95 
(35-51) 
FBSS, mixed 
neuropathies 
Legs/back NR Spontaneous eyes-
closed recording during 
post-SCS analgesia 
Power spectra of patients with 
>50% pain relief with SCS was 
comparable to healthy controls 
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Augustinsson et 
al. 1979 
Intracerebral 
recording 
1; Male 35 Stump & phantom 
limb pain 
Right stump & 
phantom leg 
2 years Peroneal nerve 
stimulation to increase 
stump pain 
SCS ↑ amplitude of early PREP 
components & ↓ amplitude of 
late PREP components in cVL 
 
Gildenberg & 
Murthy 1980 
Intracerebral 
recording 
2; Gender 
NR 
NR Stump & phantom 
limb pain, 
arachnoiditis 
Right stump & 
phantom leg; upper 
and lower limb pain 
NR Painful and non-painful 
median, sciatic, or sural 
nerve stimulation 
Short-latency SEP in VPL not 
affected by SCS. SCS modified 
80-150ms SEP component in IL 
 
Schlaier et al. 
2007 
 
TMS 5; 4 Male Range 39-50 Radiculopathy Legs/Low back NR Motor cortex 
stimulation 
ICF ↑ with SCS off and then 
reverted to baseline with SCS 
on again 
 
Abbreviations: α, alpha; β, beta; δ, delta; θ, theta; b, bilateral; c, contralateral; CHEPs, contact heat evoked potentials; D1, first digit; D5, fifth digit; EEG, electroencephalography; FBSS, failed back 
surgery syndrome; ICF, intracortical facilitation; IL, intralaminar nucleus; MCC, midcingulate cortex; MEG, magnetoencephalography; NR, not reported; PREP, pain-related evoked potential; S1, 
primary somatosensory cortex; S2, secondary somatosensory cortex; SCS, spinal cord stimulation; SEF, somatosensory evoked magnetic field; SEP, somatosensory evoked potential; TMS, 
transcranial magnetic stimulation; VL, ventrolateral thalamus; VPL, ventral posterolateral nucleus 
a = number of SCS patients 
b = mean age (unless otherwise stated) 
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Haemodynamic studies 
Ten papers investigated the effects of SCS on cortical processing using haemodynamic 
imaging techniques (functional magnetic resonance imaging (fMRI), positron emission 
tomography (PET), single photon emission computed tomography (SPECT), 133-Xe 
inhalation). These studies found a range of activity across several regions of the pain matrix, 
as identified by increases and decreases in regional cerebral blood flow (rCBF) (Table 2). 
Activity across these regions varied greatly between studies; however there appears to be a 
trend towards increased activity in frontal regions of the cortex, as well as identifying the 
anterior cingulate cortex (ACC) and thalamus as mediators of the pain experience and 
potentially key components of the influence of SCS at supraspinal levels. 
 
Additional findings (which were not displayed in Table 2 in order to ease comparison 
between studies) include differences in the velocity of regional cerebral blood flow (rCBF) 
changes dependent on the spinal cord level being stimulated and differences between good 
and poor responders to SCS. An increase in velocity of rCBF was most commonly found 
when stimulating at cervical levels of the spinal cord (Meglio et al., 1991). When looking at 
potential differences in brain activity between good and poor responders to SCS, the main 
difference found between the two groups was observed at baseline. Prior to stimulation, poor 
responders to SCS showed increased thalamic activation, whereas good responders showed 
almost no activation in the thalamus (Nagamachi et al., 2006).  
 
Cerebral neurobiological changes in response to SCS were also investigated in one study, 
which has not been included in the Table 2 as the study factors differ significantly from the 
other identified papers. Using Proton Magnetic Resonance Spectroscopy (1H-MRS), 
increases in γ-aminobutyric acid (GABA) and decreases in glucose in the ipsilateral thalamus 
were observed as a result of SCS (Moens et al., 2013a). This study further highlights the 
possible key role of the thalamus in the pain relieving mechanisms of SCS treatment.
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Table 2 Summary of findings from haemodynamic studies investigating the effect of SCS on cortical processing 
 Imaging modality Na; Gender Ageb Patient diagnoses Pain area Duration of 
SCS at 
recording 
Areas showing increased 
rCBF with SCS 
Areas showing decreased 
rCBF with SCS 
Moens et al. 
2012a 
fMRI 20; 7 Male Range 35-80 FBSS Back/legs Trial SCS NA b. Med. Thal, bACC, bPCC, 
i. Dors. PMC, i. Ant. Insula, 
i. LN, i. CN, iS1, iS2, cHPT, 
c. Insula, cS2, c. 
proprioceptive cortex, cVC, 
cPHG 
 
Stančák et al. 
2008 
fMRI 8; 5 Male Range 34-58 FBSS Low back/legs Trial SCS SCS only: M1, iS2, c. Post. 
Insula 
 
SCS & Acute heat pain: Lt. 
ITG, Rt. MTG, i. 
cerebellum 
 
SCS only: bM1, Lt. PSTS, 
Lt. temporal pole 
Kiriakopoulos et 
al. 1997 
fMRI 3; 3 Female Range 34-48 FBSS, CRPS, cauda 
equine syndrome 
 
Low 
back/buttock/leg
s 
Trial SCS S1, S2, bACC NA 
Kishima et al. 
2010 
PET 9; 6 Male Range 28-65 FBSS, CRPS, 
cerebral 
haemorrhage, spinal 
injury 
 
Legs 6-12 months Rt. Thal, Rt. OFC, Lt. Inf. 
PC, Rt. Sup. PC, Lt. ACC, 
Lt. DLPFC 
 
NA 
Sufianov et al., 
2014 
PET 30; 18 Male 48.7 ± 2.3 FBSS NR Pre-implant & 3 
months post-
implantation 
 
Pre-SCS: PCG, OFC, 
Thal, ACG 
 
Post-SCS: OFC & ACG 
markedly ↓ but still 
significantly greater than 
healthy controls 
 
Post-SCS: PCG & Thal 
activity normalised when 
compared with healthy 
controls 
 
Kunitake et al. 
2005 
SPECT 11; 9 Male 61 ± 13 (30-
76) 
Mixed neuropathies 
 
Neck/legs/arms Trial SCS (6 
patients); > 1 
year (5 patients) 
 
cThal (in central pain 
patients), bFC, bACC, cTC 
cPC 
 Page | 10   
 
Nagamachi et al. 
2006 
SPECT 18; 13 Male 47.5 ± 13.1 
(33-63) 
 
Mixed neuropathies NR Trial SCS Baseline: b. Precuneus, b. 
Cerebellum 
 
After SCS: Activation 
disappeared or was  
markedly localised 
 
Baseline: bSTG, bACG, b. 
Subcallosal gyrus 
 
After SCS: Greater decrease 
in bACG, normalised 
activity in b. Subcallosal 
gyrus, no change in bSTG 
 
 
Hosobuchi 1985 133-Xe inhalation 10; 4 Male 43.6 NR Leg/arm 3-4 weeks Cervical SCS: i. 
hemisphere 
(medial/posterior regions) 
 
 
NA 
Mazzone et al. 
1995 
133-Xe inhalation 
 
6; 3 Male Range 16-78 Mixed pathologies NR NR Global increase with acute 
SCS in 4/6 patients 
 
NA 
Meglio et al. 1991 133-Xe inhalation 8; Gender 
NR 
 
NR Mixed neuropathies Arms/legs/chest NR Focal increase in 4/8 
patients. Global increase in 
2/8 patients. 
  
Global decrease in 2/8 
patients 
Abbreviations: ACC, anterior cingulate cortex; ACG, anterior cingulate gyrus; Ant, anterior; b, bilateral; c, contralateral; CN, caudate nucleus; CRPS, complex regional pain syndrome; DLPFC, 
dorsolateral prefrontal cortex; Dors, dorsal; FBSS, failed back surgery syndrome; FC, frontal cortex; fMRI, functional magnetic resonance imaging; HPT, hypothalamus; i, ipsilateral; Inf, inferior; 
ITG, inferior temporal gyrus; LN, lentiform nucleus; Lt, left; M1, primary motor cortex; MT, medial thalamus; MTG, medial temporal gyrus; NA, not applicable; NR, not reported; OFC, orbitofrontal 
cortex; PC, parietal cortex; PCC, posterior cingulate cortex; PCG, postcentral gyrus; PET, positron emission tomography; PHG, parahippocampal gyrus; Post, posterior; PSTS, postcentral gyrus; 
rCBF, regional cerebral blood flow; Rt, right; S1, primary somatosensory cortex; S2, secondary somatosensory cortex; SCS, spinal cord stimulation; SPECT, single photon emission computed 
tomography; STG, superior temporal gyrus; Sup, superior, TC, temporal cortex; Thal, thalamus; VC, visual cortex 
a = number of SCS patients 
b = mean age (unless otherwise stated) 
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Discussion 
Theories of SCS mechanisms 
The results of this review do not allow the development of conclusive theories regarding the 
effect of SCS on cortical processing. However, some of the papers included do discuss 
potential mechanisms to explain the observed effects; particularly focusing on the collision of 
impulses theory and sensory ‘gating’ to explain the inhibition of SEPs/SEFs (Buonocore et 
al., 2012; Wolter et al., 2013). The collision of impulses theory proposes that two action 
potentials which are travelling in opposite directions (as would occur during SCS) should 
cancel each other out at the point of their collision; however this does not account for the 
increased activity found in many regions of the cortex, as highlighted by the haemodynamic 
studies in this review. Alternatively, the sensory gating hypothesis claims that the heightened 
somatosensory activity in the cortex as a result of SCS may diminish the cortical capacity to 
process pain; yet this theory does not account for why specific components of the cortical 
response to sensation and pain are inhibited while others may be intensified (Poláček et al., 
2007). It has also been posited that the activation of thalamic and parietal regions during SCS 
may reflect the influence of this treatment over pain cognition; whereas activation of 
prefrontal regions and the ACC which is displayed across many of the haemodynamic studies 
in this review may reflect the influence of SCS over the emotional aspects of pain (Kishima 
et al., 2010). Despite these theories explaining aspects of the findings regarding the influence 
of SCS on cortical processing, it is apparent that they remain unable to fully explain the 
experience. 
 
Limitations of studies 
A crucial finding from the present review is that the vast majority of papers currently 
available in this research area possess important limitations. Around half of the papers 
included within this review are over fifteen years old, using far more rudimentary imaging 
and analysis techniques than are currently available. Several of the studies included had very 
limited sample sizes, often investigating patients with heterogeneous pain areas and 
diagnoses. These patient samples also regularly included trial SCS patients for whom the 
efficacy of the treatment cannot be confirmed or failed to report the duration in which 
patients had been receiving SCS treatment.  
 
Fundamentally, the reporting of results was poor across several of the studies including, in 
some cases, omission of basic information such as patient demographics. The presence of 
these limitations in so many of the available studies creates the potential for bias within these 
publications and subsequently for the outcomes of this review to have been skewed as a 
result.  
 
A further fundamental limitation within this research area currently is that the experimental 
paradigms being employed often make it difficult to ascertain whether brain activity 
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modifications are occurring as a result of spinal cord stimulation itself or whether they are 
due to the pain relief achieved with this treatment. Therefore, it is important to maintain a 
relative amount of caution when interpreting the results of studies in this research area, and in 
turn those of this review. 
 
Due to these limiting factors and the large variation between studies both in terms of patient 
samples and methodology, the data collected as part of this review was only able to be 
reported descriptively, making it extremely difficult to draw meaningful conclusions 
regarding the mechanisms of SCS in the cortex. However, these limitations only seek to 
further highlight the importance of continued high quality research in this area.  
 
 
Directions for future research 
In order for future research to draw us closer to developing robust theories regarding the 
effect of SCS on supraspinal processing, it is fundamentally important that research in this 
area continues in a methodologically controlled and consistent manner, utilising 
advancements which are made both in neuromodulation and functional neuroimaging to 
construct more sophisticated paradigms. SCS technology has developed to produce devices 
which are MRI compatible, and these are now far more frequently implanted. Involving these 
patients in research will not only allow for more refined haemodynamic studies using 
techniques such as fMRI, but also for more accurate coregistration and analysis of data 
acquired using methods such as EEG and MEG.  
 
In addition to technological advancements in the MRI-compatibility of SCS devices, novel 
stimulation techniques have also been developed more recently, such as high-frequency SCS 
(Van Buyten et al., 2012). This stimulation technique provides analgesia for patients 
suffering from chronic neuropathic pain conditions, without producing the paresthesia 
associated with conventional SCS. Researching the brain activity modifications of 
conventional SCS does not easily lend itself to study as part of a blinded, randomised 
controlled trial which would hold more predictive power, due to the paresthesia that patients 
feel during the treatment. Although the long-term success of high-frequency SCS is yet to be 
determined, the study of patients with this type of SCS treatment could provide a means of 
investigating the associated supraspinal mechanisms as part of a blinded, controlled trial; thus 
overcoming the potential confounds associated with placebo effects and patient expectations. 
 
Future research could also further utilise paired-pulse TMS to investigate the effect of SCS 
on cortical excitability. Normalisation of this excitability, as shown by decreases in 
intracortical facilitation following SCS was described for the first time by one paper within 
this review (Schlaier et al., 2007). This study highlighted the possible role of SCS in 
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modulating neurobiological processes at a supraspinal level. Thus, in terms of increasing 
understanding of the complex interplay of mechanisms likely to be involved in the analgesic 
effects of SCS treatment, this is an area which undoubtedly warrants further exploration.  
 
Much of the research currently available in this field is diminished by the use of extremely 
small, heterogeneous patient samples. Both fMRI and MEG studies require a sample size that 
should be based on the variability of the measured parameter (standard error of the judgement 
criteria). Defining a priori the parameter of interest, the variability of this parameter and the 
difference being measured (between two groups or conditions) will provide an estimate of 
minimum sample size. It has been suggested that for studies using fMRI, a minimum sample 
size of 12 participants should be used in order to obtain 80% power with an error threshold of 
5% at a single voxel level (Desmond and Glover, 2002). However, when correcting for 
multiple comparisons, many more patients are needed; thus much larger sample sizes are 
often required to draw firm conclusions. Several factors can be optimised in order to 
minimise required sample sizes; reducing within-subject variation when using repeated 
measures study designs, maximising the effect of the intervention to enhance the difference 
between control and experimental conditions, and conducting ‘region of interest’ rather than 
whole-brain voxel-wise analyses helps to overcome the problem of multiple comparisons and 
therefore reduce sample size requirements (Zandbelt et al., 2008). To our knowledge, similar 
papers have not been published to give clear guidelines for minimum sample sizes using the 
other neurophysiological and functional imaging techniques employed in the studies 
highlighted within this review. Guidelines which provide recommendations for good practice 
in the acquisition, analysis, and reporting of MEG studies are currently available, but these 
make no estimations of minimum sample sizes for MEG studies (Gross et al., 2013). As 
suggested in the MEG good practice recommendations, it is possible to increase the validity 
of tests if the scope of the statistical analysis is limited a priori (Gross et al., 2013). The 
number of these statistical tests should be limited to the essential minimum and multiple tests 
only performed for data dimensions for which the researcher has no prior hypothesis (Gross 
et al., 2013). If we accept that a minimum sample size of 12 participants is needed in fMRI 
studies to obtain sufficient power, this indicates that 2/3 of the fMRI studies in this review are 
underpowered. Similarly, if we accept that minimum sample sizes for other 
neurophysiological and functional imaging studies should be around the same level as those 
estimated for fMRI, this highlights that the majority of studies within this review are 
underpowered due to limited samples. Within this research area, researchers should strive to 
study larger groups of patients with homogenous underlying pain conditions and symptom 
presentations, as well as ensuring patients which are being classed as good responders to the 
treatment have had fully implanted SCS therapy for a sufficient length of time to ensure that 
they are not simply having a placebo response to receiving treatment. 
 
This field of research needs to take into consideration potential confounding factors when 
interpreting results. This is the matter of identifying whether modifications in brain activity 
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which we observe are actually directly related to the mechanisms of SCS or whether they are 
occurring as a result of the pain relief attained with this treatment. Many SCS patients report 
that the pain relief they gain from this treatment does not occur instantaneously when 
stimulation is switched on. Therefore, one way in which research could address this confound 
would be by studying patients for which pain relief from SCS treatment is not immediate and 
investigating possible differences in cortical activation when patients are receiving SCS, 
between periods of time when their pain levels are still reflective of their clinical pain 
experience without stimulation and time periods when they have reached the peak of the 
analgesia they achieve with SCS. Identifying potential differences between these conditions 
would be particularly suited to study using techniques such as MEG and EEG which are well 
suited to identifying temporal changes in cortical activity. 
 
Knowledge in this area may also be significantly enhanced if future research were to focus on 
investigating any differences in cortical processing between patients for whom SCS 
successfully manages their chronic pain conditions and those with homogeneous diagnoses 
and symptom presentations that have little or no success with SCS treatment. Differences 
between these two groups were the focus of two papers included in this review, which 
observed increased contact heat evoked potentials (CHEPs) latencies in SCS responders 
when compared with non-responders (Pluijms et al., 2015), as well as identifying the 
thalamus as a possible contributor to the effectiveness of SCS (Nagamachi et al., 2006). With 
further detailed research undertaken, this research focus has the potential of identifying 
biomarkers which could determine treatment success and in turn, assist in the screening 
process of future SCS patients. 
 
 
Conclusions 
This is the first systematic review of the effects of SCS on cortical processing. The findings 
of this review suggest that SCS may play an inhibitory role in somatosensory processing, as 
well as recruiting regions of the pain matrix most closely associated with cognitive and 
emotional aspects of pain processing. However, this review also highlights the current lack of 
consensus and detailed understanding regarding the effect of SCS on the cortex; thereby 
emphasising the importance of further investigations in a more controlled manner. SCS 
remains a treatment which can produce life-changing pain relief for many patients with 
chronic neuropathic pain, and already significant progress has been made in the development 
of this neuromodulatory technique since its emergence. However, in order to continue to 
develop and understand this treatment, it is important that future research draws on these 
technological advancements to construct more controlled and sophisticated experimental 
paradigms, as well as investigate the cortical processes that differentiate between treatment 
success and failure.  
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